PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma

Oncoscience

Volumn 1, Issue 10, 2014, Pages 624-633

  Yanagi, Teruki ^a   Reed, John C ^a   Matsuzawa, Shu Ichi ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Melanoma; P27; PCTAIRE1

Indexed keywords

EID: 84923385453     PISSN: None     EISSN: 23314737     Source Type: Journal    
DOI: 10.18632/oncoscience.86     Document Type: Article

References (29)

1. Liu D, Liu X and Xing M. Activities of multiple cancerrelated pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells. Cell Cycle. 2014; 13(2):208-219.
2. Saranga-Perry V, Ambe C, Zager JS and Kudchadkar RR. Recent developments in the medical and surgical treatment of melanoma. CA Cancer J Clin. 2014; 64(3):171-185.
3. Vultur A and Herlyn M. SnapShot: melanoma. Cancer Cell. 2013; 23(5):706-706 e701.
4. Shtivelman E, Davies MQ, Hwu P, Yang J, Lotem M, Oren M, Flaherty KT and Fisher DE. Pathways and therapeutic targets in melanoma. Oncotarget. 2014; 5(7):1701-1752.
5. Cole AR. PCTK proteins: the forgotten brain kinases? Neurosignals. 2009; 17(4):288-297.
6. Le Bouffant F, Le Minter P, Traiffort E, Ruat M and Sladeczek F. Multiple subcellular localizations of PCTAIRE-1 in brain. Mol Cell Neurosci. 2000; 16(4):388-395.
7. Ou CY, Poon VY, Maeder CI, Watanabe S, Lehrman EK, Fu AK, Park M, Fu WY, Jorgensen EM, Ip NY and Shen K. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell. 2010; 141(5):846-858.
8. Mikolcevic P, Sigl R, Rauch V, Hess MW, Pfaller K, Barisic M, Pelliniemi LJ, Boesl M and Geley S. Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis. Mol Cell Biol. 2012; 32(4):868-879.
9. Liu Y, Cheng K, Gong K, Fu AK and Ip NY. Pctaire1 phosphorylates N-ethylmaleimide-sensitive fusion protein: implications in the regulation of its hexamerization and exocytosis. J Biol Chem. 2006; 281(15):9852-9858.
10. Palmer KJ, Konkel JE and Stephens DJ. PCTAIRE protein kinases interact directly with the COPII complex and modulate secretory cargo transport. J Cell Sci. 2005; 118(Pt 17):3839-3847.
11. Graeser R, Gannon J, Poon RY, Dubois T, Aitken A and Hunt T. Regulation of the CDK-related protein kinase PCTAIRE-1 and its possible role in neurite outgrowth in Neuro-2A cells. J Cell Sci. 2002; 115(Pt 17):3479-3490.
12. Cheng K, Li Z, Fu WY, Wang JH, Fu AK and Ip NY. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35. J Biol Chem. 2002; 277(35):31988-31993.
13. Charrasse S, Carena I, Hagmann J, Woods-Cook K and Ferrari S. PCTAIRE-1: characterization, subcellular distribution, and cell cycle-dependent kinase activity. Cell Growth Differ. 1999; 10(9):611-620.
14. Yanagi T, Krajewska M, Matsuzawa SI and Reed JC. PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells. Cancer Res. 2014.
15. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D and Wang Y. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 2005; 11(20):7234-7242.
16. Wang X, Gorospe M, Huang Y and Holbrook NJ. p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene. 1997; 15(24):2991-2997.
17. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997; 3(2):222-225.
18. Chu IM, Hengst L and Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008; 8(4):253-267.
19. Florenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM and Holm R. Protein expression of the cellcycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am J Pathol. 1998; 153(1):305-312.
20. Besson A, Dowdy SF and Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008; 14(2):159-169.
21. Nagano Y, Fukushima T, Okemoto K, Tanaka K, Bowtell DD, Ronai Z, Reed JC and Matsuzawa S. Siah1/SIP regulates p27(kip1) stability and cell migration under metabolic stress. Cell Cycle. 2011; 10(15):2592-2602.
22. Li Q, Murphy M, Ross J, Sheehan C and Carlson JA. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J Cutan Pathol. 2004; 31(10):633-642.
23. Katagiri Y, Hozumi Y and Kondo S. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatol Sci. 2006; 42(3):215-224.
24. Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K and Seth P. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene. 1997; 14(19):2283-2289.
25. Diersch S, Wenzel P, Szameitat M, Eser P, Paul MC, Seidler B, Eser S, Messer M, Reichert M, Pagel P, Esposito I, Schmid RM, Saur D and Schneider G. Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models. Oncotarget. 2013; 4(2):277-288.
26. Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y and Gleave ME. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res. 2008; 14(18):5769-5777.
27. Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I and Tsukuda M. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Oncol Rep. 2004; 11(2):421-426.
28. Wiederschain D, Wee S, Chen L, Loo A, Yang G, Huang A, Chen Y, Caponigro G, Yao YM, Lengauer C, Sellers WR and Benson JD. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 2009; 8(3):498-504.
29. Krajewska M, Smith LH, Rong J, Huang X, Hyer ML, Zeps N, Iacopetta B, Linke SP, Olson AH, Reed JC and Krajewski S. Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem. 2009; 57(7):649-663.